EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms

Jiwon Yun iD, Hye Ryoun Kim iD

Annals of Laboratory Medicine · 2025

DOI: 10.3343/alm.2024.0079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2025. Verfasst von Jiwon Yun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: RNA Splicing Factors, World Health Organization, Myelodysplastic Syndromes, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsWorld Health OrganizationMyelodysplastic SyndromesTumor Suppressor Protein p53MutationPhosphoproteinsHumansAgedMaleFemaleMiddle AgedProportional Hazards ModelsAged, 80 and overCore Binding Factor Alpha 2 SubunitAdultPrognosisGene FrequencyKaplan-Meier EstimateRisk FactorsConsensusSurvival Analysis

Stichwörter der Autor:innen

Information sourcesInternational Consensus ClassificationMyelodysplastic syndromesSF3B1TP53WHO Classification

Substanzen

SF3B1 protein, humanRNA Splicing FactorsTumor Suppressor Protein p53PhosphoproteinsTP53 protein, humanCore Binding Factor Alpha 2 Subunit

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

ORCID-Profile: Jiwon Yun, Hye Ryoun Kim

Förderung

  • National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Yun, J., & Kim, H. R. (2025). Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.0079

Vancouver

Yun J, Kim HR. Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms. Annals of Laboratory Medicine. 2025. doi:10.3343/alm.2024.0079

BibTeX
@article{Yun2025,
  author = {Yun, Jiwon and Kim, Hye Ryoun},
  title = {Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms},
  journal = {Annals of Laboratory Medicine},
  year = {2025},
  doi = {10.3343/alm.2024.0079}
}
Kostenlos starten →